Intellia Therapeutics, Inc. NTLA
Set alert
12.47 USD -0.76 -5.74%
At close
12.35 -0.12 -0.95%
Pre-market · Nov 2, 4:00 AM ET
12.04 Day range 13.13
7.95 52-week range 18.48
- YTD
- +38.71%
- 1 year
- -1.19%
- Open
- 12.82
- Prev close
- 13.23
- Mkt cap
- 1.75B
- Vol
- 4.09M
- Avg vol
- 4.38M
- EPS
- -3.35
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 12.04
- High
- 13.13
- Forward P/E
- -4.86
- Beta
- 1.80
- Short ratio
- 7.63
- Inst. own
- 100.56%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 12.23
- 200-d avg
- 13.08
- 1y target
- 23.11
MAX chart
Events in this range
- Aug 7, 2025Earnings: -0.99; estimate -1.03; surprise 3.88%
- Nov 6, 2025Earnings: -0.92; estimate -1.02; surprise 9.8%
- Aug 6, 2026Earnings: -0.8; estimate -0.79927; surprise -0.09%
- Aug 7, 2026Rating: Evercore ISI Group · In-Line → Outperform
- Oct 6, 2026Rating: Barclays · — → Underweight
Signals (32)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 1, 2026 | 3 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | Jan 1, 2026 | 10 months ago |
| SMA: Bearish | Nov 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 1, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 1, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Jul 1, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 1, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2023 | 3 years ago |
| SMA: Bullish | Jul 1, 2023 | 3 years ago |
| SMA: Bearish | Apr 1, 2022 | 4 years ago |
| MACD: Sell Signal | Feb 1, 2022 | 4 years ago |
| SMA: Bearish | Dec 1, 2021 | 4 years ago |
| RSI: Overbought | Nov 1, 2020 | 6 years ago |
| SMA: Bullish | Aug 1, 2020 | 6 years ago |
| SMA: Bearish | Jul 1, 2020 | 6 years ago |
| SMA: Bullish | Jun 1, 2020 | 6 years ago |
| MACD: Buy Signal | Jun 1, 2020 | 6 years ago |
| SMA: Bullish | May 1, 2020 | 6 years ago |
| SMA: Bearish | Dec 1, 2019 | 6 years ago |
| SMA: Bullish | Nov 1, 2019 | 7 years ago |
| SMA: Bearish | Aug 1, 2019 | 7 years ago |
| SMA: Bullish | Jul 1, 2019 | 7 years ago |
| SMA: Bearish | Oct 1, 2018 | 8 years ago |
| SMA: Bullish | May 1, 2018 | 8 years ago |
| SMA: Bearish | Mar 1, 2018 | 8 years ago |
| SMA: Bullish | Jun 1, 2017 | 9 years ago |
Ownership
Held by insiders 3.84%
Held by institutions 100.56%
Float held by institutions 104.57%
Institutions 432
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK Investment Management, LLC | 12.04% | 16,875,684 | 210.44M | Jun 29, 2026 |
| Blackrock Inc. | 11.00% | 15,409,023 | 192.15M | Jun 29, 2026 |
| State Street Corporation | 6.59% | 9,234,987 | 115.16M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.23% | 7,332,401 | 91.44M | Jun 29, 2026 |
| Shaw D.E. & Co., Inc. | 4.60% | 6,443,323 | 80.35M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.30% | 6,028,586 | 75.18M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK ETF Trust-ARK Innovation ETF | 7.40% | 10,368,179 | 129.29M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.06% | 4,286,200 | 53.45M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 3.06% | 4,286,323 | 53.45M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.54% | 3,564,714 | 44.45M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.22% | 3,106,242 | 38.73M | Jun 29, 2026 |
| ARK ETF Trust-ARK Genomic Revolution ETF | 1.98% | 2,781,291 | 34.68M | Sep 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BASTA JAMES EDMUND | General Counsel | Sale | Mar 1, 2026 | 156,794 |
| CHASE WILLIAM J | Director | Stock Award(Grant) | Jun 8, 2026 | 143,893 |
| CLARK ELIANA | Chief Technology Officer | Sale | Mar 1, 2026 | 93,864 |
| COHEN FREDERICK E. M.D. PH.D. | Director | Stock Award(Grant) | Jun 8, 2026 | 216,653 |
| DULAC EDWARD J III | Chief Financial Officer | Sale | Jul 21, 2026 | 148,175 |
| LEBWOHL DAVID | Officer | Stock Award(Grant) | Feb 26, 2026 | 131,192 |
Held by funds
114 US ETFs and mutual funds hold NTLA · largest positions